352 related articles for article (PubMed ID: 27608656)
21. Prevention and treatment of chemotherapy-induced peripheral neuropathy.
Piccolo J; Kolesar JM
Am J Health Syst Pharm; 2014 Jan; 71(1):19-25. PubMed ID: 24352178
[TBL] [Abstract][Full Text] [Related]
22. Targeting human 8-oxoguanine DNA glycosylase (hOGG1) to mitochondria enhances cisplatin cytotoxicity in hepatoma cells.
Zhang H; Mizumachi T; Carcel-Trullols J; Li L; Naito A; Spencer HJ; Spring PM; Smoller BR; Watson AJ; Margison GP; Higuchi M; Fan CY
Carcinogenesis; 2007 Aug; 28(8):1629-37. PubMed ID: 17389610
[TBL] [Abstract][Full Text] [Related]
23. Prevention of chemotherapy-induced peripheral neuropathy by the small-molecule inhibitor pifithrin-μ.
Krukowski K; Nijboer CH; Huo X; Kavelaars A; Heijnen CJ
Pain; 2015 Nov; 156(11):2184-2192. PubMed ID: 26473292
[TBL] [Abstract][Full Text] [Related]
24. Acetyl-L-carnitine for the treatment of chemotherapy-induced peripheral neuropathy: a short review.
De Grandis D
CNS Drugs; 2007; 21 Suppl 1():39-43; discussion 45-6. PubMed ID: 17696592
[TBL] [Abstract][Full Text] [Related]
25. Chemotherapy-induced peripheral neuropathy.
Fehrenbacher JC
Prog Mol Biol Transl Sci; 2015; 131():471-508. PubMed ID: 25744683
[TBL] [Abstract][Full Text] [Related]
26. The inhibitor of the redox activity of APE1/REF-1, APX2009, reduces the malignant phenotype of breast cancer cells.
Siqueira PB; Rodrigues MMS; Amorim ĹSS; Rodrigues JA; Oliveira MS; Fonseca AS; Pires BRB; Mencalha AL
Braz J Med Biol Res; 2024; 57():e13250. PubMed ID: 38808886
[TBL] [Abstract][Full Text] [Related]
27. Peripheral neuropathy in colorectal cancer survivors: the influence of oxaliplatin administration. Results from the population-based PROFILES registry.
Beijers AJ; Mols F; Tjan-Heijnen VC; Faber CG; van de Poll-Franse LV; Vreugdenhil G
Acta Oncol; 2015 Apr; 54(4):463-9. PubMed ID: 25417732
[TBL] [Abstract][Full Text] [Related]
28. Isolation of a small molecule inhibitor of DNA base excision repair.
Madhusudan S; Smart F; Shrimpton P; Parsons JL; Gardiner L; Houlbrook S; Talbot DC; Hammonds T; Freemont PA; Sternberg MJ; Dianov GL; Hickson ID
Nucleic Acids Res; 2005; 33(15):4711-24. PubMed ID: 16113242
[TBL] [Abstract][Full Text] [Related]
29. Updating your peripheral neuropathy "know-how".
Marrs J; Newton S
Clin J Oncol Nurs; 2003; 7(3):299-303. PubMed ID: 12793336
[TBL] [Abstract][Full Text] [Related]
30. Dietary Intake of Magnesium or Calcium and Chemotherapy-Induced Peripheral Neuropathy in Colorectal Cancer Patients.
Wesselink E; Winkels RM; van Baar H; Geijsen AJMR; van Zutphen M; van Halteren HK; Hansson BME; Radema SA; de Wilt JHW; Kampman E; Kok DEG
Nutrients; 2018 Mar; 10(4):. PubMed ID: 29570617
[TBL] [Abstract][Full Text] [Related]
31. Prevention and Treatment for Chemotherapy-Induced Peripheral Neuropathy: Therapies Based on CIPN Mechanisms.
Hu LY; Mi WL; Wu GC; Wang YQ; Mao-Ying QL
Curr Neuropharmacol; 2019; 17(2):184-196. PubMed ID: 28925884
[TBL] [Abstract][Full Text] [Related]
32. Prevention of anticancer therapy-induced neurotoxicity: Putting DNA damage in perspective.
Brinkmann V; Fritz G
Neurotoxicology; 2022 Jul; 91():1-10. PubMed ID: 35487345
[TBL] [Abstract][Full Text] [Related]
33. Alpha-lipoic acid prevents mitochondrial damage and neurotoxicity in experimental chemotherapy neuropathy.
Melli G; Taiana M; Camozzi F; Triolo D; Podini P; Quattrini A; Taroni F; Lauria G
Exp Neurol; 2008 Dec; 214(2):276-84. PubMed ID: 18809400
[TBL] [Abstract][Full Text] [Related]
34. A dominant-negative form of the major human abasic endonuclease enhances cellular sensitivity to laboratory and clinical DNA-damaging agents.
McNeill DR; Wilson DM
Mol Cancer Res; 2007 Jan; 5(1):61-70. PubMed ID: 17259346
[TBL] [Abstract][Full Text] [Related]
35. Platinum-induced peripheral neurotoxicity: From pathogenesis to treatment.
Staff NP; Cavaletti G; Islam B; Lustberg M; Psimaras D; Tamburin S
J Peripher Nerv Syst; 2019 Oct; 24 Suppl 2(Suppl 2):S26-S39. PubMed ID: 31647151
[TBL] [Abstract][Full Text] [Related]
36. The Role of Nucleotide Excision Repair in Cisplatin-Induced Peripheral Neuropathy: Mechanism, Prevention, and Treatment.
Acklin S; Xia F
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33671279
[TBL] [Abstract][Full Text] [Related]
37. Receptor-based virtual screening and biological characterization of human apurinic/apyrimidinic endonuclease (Ape1) inhibitors.
Ruiz FM; Francis SM; Tintoré M; Ferreira R; Gil-Redondo R; Morreale A; Ortiz ÁR; Eritja R; Fàbrega C
ChemMedChem; 2012 Dec; 7(12):2168-78. PubMed ID: 23109358
[TBL] [Abstract][Full Text] [Related]
38. Role for Drug Transporters in Chemotherapy-Induced Peripheral Neuropathy.
Stage TB; Hu S; Sparreboom A; Kroetz DL
Clin Transl Sci; 2021 Mar; 14(2):460-467. PubMed ID: 33142018
[TBL] [Abstract][Full Text] [Related]
39. Chemotherapy-induced peripheral neuropathy-part 2: focus on the prevention of oxaliplatin-induced neurotoxicity.
Sałat K
Pharmacol Rep; 2020 Jun; 72(3):508-527. PubMed ID: 32347537
[TBL] [Abstract][Full Text] [Related]
40. Decisive role of apurinic/apyrimidinic endonuclease/Ref-1 in initiation of cell death.
Cho KJ; Kim HJ; Park SC; Kim HW; Kim GW
Mol Cell Neurosci; 2010 Nov; 45(3):267-76. PubMed ID: 20637286
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]